Paul de Potocki

Paul de Potocki is currently the Chairman at Asarina Pharma AB, a Director at Palette Life Sciences, Inc., and an Independent Director at ProstaLund AB. Previously, he served as the President & Chief Executive Officer at Aerocrine AB from 2007 to 2011, the President, CEO & Head-Investor Relations at NEL ASA in 2014, the Chief Executive Officer at OncoZenge AB from 2021 to 2023, and a Director at Athera Biotechnologies AB from 2010 to 2013.
He also held positions as the Global Vice President-Commercial Operations at Biovitrum AB from 2001 to 2006, Fresenius Kabi AB, and Pharmacia & Upjohn AB. Mr. de Potocki holds an MBA from the London School of Economics & Political Science and a graduate degree from the Royal Institute of Technology.